Asset Details
Do you wish to reserve the book?
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Do you wish to request the book?
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
2022
Overview
In the prevention and treatment of infectious diseases, mRNA vaccines hold great promise because of their low risk of insertional mutagenesis, high potency, accelerated development cycles, and potential for low-cost manufacture. In past years, several mRNA vaccines have entered clinical trials and have shown promise for offering solutions to combat emerging and re-emerging infectious diseases such as rabies, Zika, and influenza. Recently, the successful application of mRNA vaccines against COVID-19 has further validated the platform and opened the floodgates to mRNA vaccine’s potential in infectious disease prevention, especially in the veterinary field. In this review, we describe our current understanding of the mRNA vaccines and the technologies used for mRNA vaccine development. We also provide an overview of mRNA vaccines developed for animal infectious diseases and discuss directions and challenges for the future applications of this promising vaccine platform in the veterinary field.
Publisher
MDPI AG,MDPI
Subject
/ Antigens
/ Communicable Disease Control
/ Communicable Diseases - classification
/ Communicable Diseases - virology
/ Communicable Diseases, Emerging - immunology
/ Communicable Diseases, Emerging - prevention & control
/ COVID-19
/ Enzymes
/ Genes
/ Humans
/ Kinases
/ mRNA
/ mRNA Vaccines - classification
/ Proteins
/ Rabies
/ Review
/ risk
/ Severe acute respiratory syndrome coronavirus 2
/ vaccines
/ Vaccines, Synthetic - analysis
/ Vaccines, Synthetic - classification
/ Vaccines, Synthetic - genetics
/ Vaccines, Synthetic - immunology
/ viruses
/ Zoonoses
